Compare APLD & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APLD | CRL |
|---|---|---|
| Founded | 2001 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 8.0B |
| IPO Year | N/A | 2000 |
| Metric | APLD | CRL |
|---|---|---|
| Price | $32.04 | $187.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | $29.36 | ★ $190.15 |
| AVG Volume (30 Days) | ★ 26.7M | 919.6K |
| Earning Date | 01-13-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $173,560,000.00 | ★ $4,023,704,000.00 |
| Revenue This Year | $113.90 | N/A |
| Revenue Next Year | $71.28 | $1.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 28.43 | N/A |
| 52 Week Low | $3.31 | $91.86 |
| 52 Week High | $40.20 | $202.72 |
| Indicator | APLD | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 63.75 | 65.14 |
| Support Level | $26.86 | $176.37 |
| Resistance Level | $30.30 | $186.72 |
| Average True Range (ATR) | 2.52 | 5.74 |
| MACD | 1.00 | 1.93 |
| Stochastic Oscillator | 98.61 | 94.36 |
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.